Cue Biopharma, Inc.

NASDAQ:CUE

Biotechnology

Healthcare
$14.10 +1.42%

+$0.38 today

Market cap
$102.43M
Beta
2.53
P/E (TTM)
-6.7
EPS (TTM)
-$4.06
52W Low $4.98High $41.42

Volume 0.21M

Average 0.74M

Price history

Cue Biopharma, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-13.07%

Period high

$37.84

Period low

$5.31

Latest

$14.10

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
SC 13G/ANov 10, 2026Nov 10, 2026
4Oct 14, 2026Oct 14, 2026
4Oct 14, 2026Oct 14, 2026
4Oct 14, 2026Oct 14, 2026
SC 13G/AOct 8, 2026Oct 8, 2026
8-KSep 21, 2026Sep 21, 2026
4/AAug 28, 2026Aug 28, 2026
4/AAug 28, 2026Aug 28, 2026
SC 13DAug 21, 2026Aug 21, 2026
EFFECTAug 20, 2026Aug 21, 2026
4Aug 17, 2026Aug 17, 2026
4Aug 17, 2026Aug 17, 2026
8-KAug 14, 2026Aug 14, 2026
10-QAug 14, 2026Aug 14, 2026
4Aug 14, 2026Aug 14, 2026

Competitors

Who does Cue Biopharma, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about CUE's filings, answered from its disclosures.

What is the latest CUE filing?

The latest filing shown is SC 13G/A dated Nov 10, 2026.

How many recent filings does CUE have?

Intrinsic Alpha currently shows 20 recent filings for CUE.